Latest Global Expansion News

Janison Education Group has renewed its $2 million contract with Chartered Accountants Australia and New Zealand, while debuting its AI-powered platform Jai in a landmark commercial deployment.

Talius Group has secured its first purchase order from Wesco Anixter and signed a global expansion agreement, while subscription numbers near 49,000 amid ongoing pilot programs and regulatory shifts.

Titomic’s Netherlands division has secured €800,000 in funding from the Dutch 3D Print Kompas program to advance its Cold Spray Additive Manufacturing technology, aiming to expand R&D and industrial applications across Europe.

Proteomics International has achieved a major milestone with the first worldwide patent granted in Japan for its PromarkerEndo blood test, designed to diagnose endometriosis early and accurately.

X2M Connect Limited has secured over $5.5 million in new South Korean contracts for remote water metering, signaling strong momentum heading into FY26. The company’s expanding customer base and addressable market highlight its growing influence in the Asia-Pacific IoT sector.

Ionic Rare Earths is advancing plans for multiple magnet recycling plants in the US, leveraging patented technology to produce high-purity rare earth oxides amid growing demand for sovereign supply chains.

X2M Connect has secured a $3 million deal to supply 100,000 IoT-connected personal safety devices for Seoul’s 2025 Smart City initiative, with potential to scale to one million units.

Eden Innovations is set to consolidate its shares and launch a $6.6 million entitlement offer to reduce debt and fund global expansion of its EdenCrete® and OptiBlend® products.

Bioxyne Limited has upgraded its FY2025 revenue guidance to approximately $28 million, driven by strong domestic performance and significant progress in European and UK markets. The company also advances its psychedelic medicines pipeline, positioning itself for sustained growth.

xReality Group is rapidly transforming its business by focusing on its high-growth Operator XR training platform, while preparing to divest legacy entertainment assets. The company reports record revenue and expanding global reach, particularly in the US defence and law enforcement sectors.

Orthocell’s new study confirms Remplir™ delivers superior nerve regeneration and faster muscle recovery compared to traditional sutures, bolstering its US market rollout plans.

Bioxyne Limited's subsidiary Breathe Life Sciences has achieved key GMP certifications across multiple international markets, paving the way for expanded operations in Europe, the UK, Canada, and Singapore. The company signals strong growth prospects for FY2026, with formal guidance expected in August.